Watching HIV bud from cells
ScienceDaily - 17-May-2014
Between Roquefort and Camembert: Multiple recent gene transfers
ScienceDaily - 17-May-2014
J&J and Pfizer pursue contrasting strategies, AZ backs biotech fund, Bayer opens Berlin incubator
Fierce Biotech - 17-May-2014
FDA rejects Novartis' 'breakthrough' cardio drug serelaxin
Fierce Biotech - 17-May-2014
Proteon banks $45M for vascular drug with Novartis in the rearview
Fierce Biotech - 17-May-2014
Gates, Wellcome bet $40M on Kymab's antibody tech
Fierce Biotech - 17-May-2014
Gelesis brings in $12M to advance its obesity pill
Fierce Biotech - 17-May-2014
Forest CEO Saunders to lead combined company after Actavis buyout
Fierce Biotech - 17-May-2014
Kamada tanks as its lead drug can't top placebo
Fierce Biotech - 17-May-2014
Pfizer's vows fall on deaf ears in Cambridge
Fierce Biotech - 17-May-2014
Customizing antibodies by learning from sharks
ScienceDaily - 16-May-2014
Secret of radiation vulnerability revealed by research
ScienceDaily - 16-May-2014
Combination therapy a potential strategy for treating Niemann Pick disease
ScienceDaily - 16-May-2014
First test of pluripotent stem cell therapy in monkeys is successful
ScienceDaily - 16-May-2014
Cancer's potential on-off switch linked to epigenetics
ScienceDaily - 16-May-2014
Single episode of binge drinking can adversely affect health, according to new study
ScienceDaily - 16-May-2014
First 'heavy mouse' leads to first lab-grown tissue mapped from atomic life
ScienceDaily - 16-May-2014
How some trypanosomes cause sleeping sickness while others don't
ScienceDaily - 16-May-2014
Novartis-backed Sorbent grabs first tranche in $15M heart therapy round
Fierce Biotech - 16-May-2014
Novel genetic mechanism protects plants from toxic zinc
ScienceDaily - 16-May-2014